Navigation Links
Aton Pharma Acquires U.S. TIMOPTIC(R)
Date:2/25/2009

"This is particularly problematic in glaucoma patients, who must use medication frequently and for long periods of time. Preservative-free product options are important for these patients with dry eyes."**

Aton's market research indicates that more than 60% of ophthalmologists are unaware that preservative-free preparations of timolol are available. The use of preservative-containing glaucoma medications in patients with compromised ocular surface issues is of particular concern to nearly 80% of ophthalmologists.

"As we have done with LACRISERT and other Aton products, we will concentrate on enhancing distribution, sampling and reimbursement assistance while increasing patient and provider awareness for TIMOPTIC in OCUDOSE(R)," added Mr. Wells.

TIMOPTIC in OCUDOSE(R), along with TIMOPTIC(R) and TIMOPTIC XE(R), is indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. TIMOPTIC in OCUDOSE(R) , TIMOPTIC(R), and TIMOPTIC-XE(R) are contraindicated in patients with bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; overt cardiac failure; cardiogenic shock; or hypersensitivity to any component of this product. Because of the potential effects of beta-adrenergic blocking agents on blood pressure and pulse, these agents should be used with caution in patients with cerebrovascular insufficiency. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical ophthalmic administration.

LACRISERT is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. Most adverse reactions with LACRISERT were mild and transient and included transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyel
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Momentum Launches Anti-Counterfeiting Software for Pharmaceutical Companies
2. Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsukas Pharmaceutical Business Worldwide
3. Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan
4. Pharmacyclics Receives Nasdaq Notification
5. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
6. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
7. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
8. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
9. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
10. Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression
11. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent natural ... found the amino acid creatine, which athletes typically use to ... pressure. , The report is part of the ... ,” which Royal River Natural Foods publishes each month as ... the latest in nutrition science. Also in the April issue, ...
(Date:4/1/2015)... VA. (PRWEB) April 01, 2015 One year ... Warrior and Family Care Center in the United States and ... more than 16,000 square feet facility has served more than ... 50% of these visitors were wounded, ill and injured and ... of the nation’s largest military medical centers in the country. ...
(Date:4/1/2015)... Irvine, CA (PRWEB) April 01, 2015 ... for commercial, industrial and residential applications now offers a ... install its wide range of bird netting products quickly, ... crucial to the success of any bird netting installation. ... needed in the planning stages of a project. This ...
(Date:4/1/2015)... 01, 2015 The Path Adventures has recently ... adventure you could ever embark upon. Trips range from a ... the Philippine Department of Tourism, these trips are not to ... very few people have ever been in virgin (uninhabited by ... with nothing more than a backpack full of supplies, adventure ...
(Date:4/1/2015)... 01, 2015 New Jersey Governor ... other First Spouses from across the country in ... 21, 2015, World Down Syndrome Day(WDSD), to increase ... advancing area of Down syndrome cognition research. , ... Alabama, Alaska, American Samoa, Arizona, California, Colorado, Delaware, ...
Breaking Medicine News(10 mins):Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 3Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 4Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 5Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2
... to a recent IOM report, only 6 percent of ... care for children. With high rates of novel H1N1 ... these deficiencies is immediate. , In a joint ... Care of Children in the Emergency Department," pediatric emergency ...
... have ample evidence that individuals use a variety of cues ... in families other than their own. A new study shows ... or not those families are the same race as themselves. ... Journal of Vision ("Cross-cultural perceptions of facial resemblance between ...
... , , NEW YORK, Sept. 21 ... first impression. The fall season ushers in many first encounters, from the ... Looking and feeling your best will help you exude confidence, so follow ... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/crest/39172/ ...
... September 21 Health Robotics today,announced that it ... Technologies Australia Pty Ltd. for its revolutionary,CytoCare(TM) Robot. ... its goal of safely, accurately and cost-effectively,automating the ... market-leading Oncology and Surgery Robotic solutions. , ...
... 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) ... review of the HTDS business model. ECM ... HTDS followers at the following link ... (ECM) believes that in the current economic ...
... ... TCO by Streamlining IT Audit Processes, Harmonizing Controls with Policy Requirements, and Providing Greater IT ... ... , , ,News Facts:, , ,A typical organization spends 30-50% more on compliance and IT ...
Cached Medicine News:Health News:Race has little effect on people's ability to spot family resemblances 2Health News:Photos: Fall's First Impressions 2Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 2Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 3Health News:Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS) 2Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 2Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 3Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 4Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 5Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 6Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 7
(Date:4/1/2015)... Salix Pharmaceuticals, Ltd. (the " Company " ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... Fundamental Changes, Make-Whole Fundamental Changes and Merger Event, Fundamental ... and Offer to Purchase (the " Notice ") to ... (the " Notes "), pursuant to the Indenture, dated ...
(Date:4/1/2015)... -- New York College of Health Professions announces a valuable ... U.S. Patent #8,996,098 donated by its Chairman under the ... instrument that allows surgeons to view and compare what ... traditional format of a slide that is used during ... thus providing the surgeon real time analysis and information. ...
(Date:4/1/2015)... , April 1, 2015  Hologic, Inc. (NASDAQ: ... holders of the 2.00% Convertible Exchange Senior Notes due ... and Wilmington Trust Company, the trustee, paying agent and ... to convert the notes.  This conversion right is subject ... notes dated as of December 10, 2007, as supplemented ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2
... Feb. 19, 2011 Genoptix, Inc. (Nasdaq: ... a memorandum of understanding ("MOU") providing for the settlement ... the Superior Court of the State of California, San ... Genoptix, Inc., Case No. 37-2011-00050762-CU-BT-NC, (2) Schwitters v. Genoptix, ...
... 18, 2011 TLC Vision announced today its plans for ... in San Diego.  Internationally recognized as leaders in field of ... Tanzer MD will lend their surgical skill and expertise to ... center will continue to be at the forefront of working ...
Cached Medicine Technology:Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 2Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 3Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 4Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 5Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 6Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 7Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 8Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 9Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 10Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 11TLC Vision Announces TLC Laser Eye Center San Diego 2
Inquire...
Microalbumin Linearity Control...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Rapid test for mononucleosis...
Medicine Products: